Free Trial

Oscar Health Sees Unusually High Options Volume (NYSE:OSCR)

Oscar Health logo with Finance background

Oscar Health, Inc. (NYSE:OSCR - Get Free Report) was the target of unusually large options trading on Tuesday. Traders bought 20,164 call options on the company. This represents an increase of approximately 81% compared to the typical daily volume of 11,150 call options.

Oscar Health Trading Up 10.7%

Shares of OSCR stock traded up $1.52 on Thursday, reaching $15.67. 30,373,465 shares of the stock were exchanged, compared to its average volume of 4,595,748. The stock has a market cap of $3.99 billion, a P/E ratio of -782.86 and a beta of 1.73. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. The firm has a 50 day moving average of $13.78 and a two-hundred day moving average of $14.58. Oscar Health has a 1-year low of $11.20 and a 1-year high of $23.79.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.83 by $0.09. Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. The firm had revenue of $3 billion during the quarter, compared to the consensus estimate of $2.87 billion. During the same period in the prior year, the firm earned $0.62 EPS. The firm's quarterly revenue was up 42.2% compared to the same quarter last year. On average, research analysts anticipate that Oscar Health will post 0.69 EPS for the current year.

Analyst Ratings Changes

A number of equities research analysts have weighed in on OSCR shares. Wells Fargo & Company lowered Oscar Health from an "overweight" rating to an "equal weight" rating and lowered their price objective for the company from $20.00 to $16.00 in a report on Thursday, March 13th. Wall Street Zen raised Oscar Health from a "hold" rating to a "buy" rating in a research note on Saturday, May 31st. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, Oscar Health currently has an average rating of "Hold" and a consensus price target of $18.50.

Read Our Latest Report on OSCR

Insider Transactions at Oscar Health

In related news, Director Elbert O. Jr. Robinson sold 25,000 shares of the business's stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $16.43, for a total value of $410,750.00. Following the transaction, the director now owns 64,512 shares in the company, valued at $1,059,932.16. The trade was a 27.93% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 24.39% of the company's stock.

Hedge Funds Weigh In On Oscar Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in OSCR. Barclays PLC boosted its position in Oscar Health by 217.5% in the 3rd quarter. Barclays PLC now owns 325,818 shares of the company's stock valued at $6,911,000 after buying an additional 223,189 shares during the last quarter. Janney Montgomery Scott LLC lifted its holdings in Oscar Health by 24.2% in the fourth quarter. Janney Montgomery Scott LLC now owns 57,850 shares of the company's stock worth $778,000 after acquiring an additional 11,282 shares during the last quarter. KBC Group NV lifted its holdings in Oscar Health by 56.1% in the fourth quarter. KBC Group NV now owns 7,107 shares of the company's stock worth $96,000 after acquiring an additional 2,555 shares during the last quarter. GDS Wealth Management lifted its holdings in Oscar Health by 1,545.3% in the fourth quarter. GDS Wealth Management now owns 345,817 shares of the company's stock worth $4,648,000 after acquiring an additional 324,798 shares during the last quarter. Finally, Tempus Wealth Planning LLC bought a new position in Oscar Health in the fourth quarter worth about $181,000. 75.70% of the stock is owned by hedge funds and other institutional investors.

About Oscar Health

(Get Free Report)

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

Further Reading

Should You Invest $1,000 in Oscar Health Right Now?

Before you consider Oscar Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.

While Oscar Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome
Top 5 Stocks for June: AI Picks That Aren’t NVIDIA

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines